Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Minden
Clinical trial register · Germany

Clinical Trials in Minden, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sanofi5 Merck Sharp & Dohme LLC3 GlaxoSmithKline3 AbbVie3 Viatris Innovation GmbH2
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Minden

41 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Takeda
Phase 3
324
Freiburg im Breisgau, Heidelberg, Mutlangen, Minden, Koblenz, Chemnitz, Halle, Jena
2026-09-10
Recruiting
Boehringer Ingelheim
Phase 2
405
Minden, München
2026-04-20
Recruiting
Sanofi
Phase 3
751
Tübingen, Ulm, Leipzig, Halle, Kiel, Berlin, Minden
2026-01-16
Recruiting
Incyte Corporation
Phase 3
466
Berlin, Bonn, Dresden, Essen, Kassel, Kiel, Mannheim, Minden
2025-12-09
Recruiting
A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
NCT07203768Polycythemia Vera, Thrombocythemia
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
678
Halle, Hanover, Minden
2025-12-01
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Heidelberg, Stuttgart, Tübingen, Düsseldorf, Herne, Minden, Chemnitz, Jena
2025-11-25
Recruiting
Sanofi
Phase 3
980
Berlin, Herne, Kiel, Leipzig, Minden, Ulm
2025-10-08
Recruiting
Sanofi
Phase 3
124
Berlin, Erlangen, Hanover, Minden, Ulm
2025-09-26
Recruiting
ARTICE® Real Data Collection & Observational Trial, Phase 4 Study
NCT07388628Sepsis, Septic Shock, Immunoparalysis in Septic Shock
Artcline GmbH
Observational
200
Magdeburg, Minden
2025-09-25
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
34
Erfurt, Erlangen, Heidelberg, Leipzig, Minden, Oberhausen, Tübingen
2025-08-07
Recruiting
Pharmazz, Inc.
Phase 3
514
Altenburg, Göttingen, Rhein, Minden, Recklinghausen, Berlin, Bad Neustadt an der Saale, Erlangen
2025-07-24
Active, closed
Sanofi
Phase 2
105
Minden, Kiel, Ulm
2025-07-07
Active, closed
AbbVie
Phase 3
573
Freiburg im Breisgau, Ulm, Dachau, Erlangen, Regensburg, Frankfurt am Main, Essen, Minden
2025-06-17
Recruiting
Sanofi
Phase 2
99
Minden, Jena, Kiel, Ulm
2025-06-03
Recruiting
PEEP vs. ZEEP in Out-of-Hospital-Cardiac-Arrest
NCT06836830Ventilation Therapy, PEEP, Occult, CPR, Cardiac Arrest (CA)
Muehlenkreiskliniken, MKK
Not applicable
600
Gütersloh, Minden, Osnabrück
2025-06-01
Recruiting
Eikon Therapeutics
Phase 2/3
740
Mannheim, Tübingen, Würzburg, Erlangen, Martinsried, Haus, Buxtehude, Minden
2025-05-22
Recruiting
University Hospital, Bonn
Phase 2
176
Freiburg im Breisgau, Stuttgart, Giessen, Minden, Bonn
2025-04-20
Recruiting
Gilead Sciences
Phase 3
695
Berlin, Bochum, Chemnitz, Esslingen am Neckar, Hamburg, Löwenstein, Minden, Munich
2025-04-04
Recruiting
Summit Therapeutics
Phase 3
780
Chemnitz, Esslingen am Neckar, Gauting, Giesen, Halle, Herne, Karlsruhe, Minden
2025-02-27
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Bad Bentheim, Berlin, Dresden, Freiburg im Breisgau, Hamburg, Herne, Langenau, Minden
2025-02-21
Recruiting
AIO-Studien-gGmbH
Phase 2
57
Berlin, Dresden, Essen, Flensburg, Frankfurt, Minden, München, Stuttgart
2025-01-01
Active, closed
argenx
Phase 2
87
Bad Bramstedt, Lübeck, Minden, Tübingen
2024-11-11
Recruiting
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
617
Halle, Hanover, Minden
2024-10-14
Recruiting
GlaxoSmithKline
Phase 3
440
Essen, Minden, Mainz, Würzburg
2024-09-11
By invitation
Viatris Innovation GmbH
Phase 3
680
Leipzig, Minden
2024-07-30
Active, closed
AbbVie
Observational
1,200
Dachau, Lüneburg, Oldenburg, Minden, Buedelsdorf, Lübeck, Jena, Berlin
2024-02-19
Active, closed
AOP Orphan Pharmaceuticals AG
Phase 3
117
Aachen, Halle, Hanover, Mannheim, Minden, Ulm
2023-12-04
Active, closed
AstraZeneca
Phase 3
314
Freiburg im Breisgau, Mainz, Minden, Münster, Tübingen
2023-11-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Ulm, Dachau, Munich, Frankfurt am Main, Hanover, Lüneburg, Duisburg, Minden
2023-10-25
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
DrugBelimumab
GlaxoSmithKline
Phase 2/3
300
Minden, Mainz, Cologne, Düsseldorf, Tübingen
2023-09-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Mannheim, Augsburg, München, Göttingen, Rostock, Cologne, Essen, Minden
2023-07-19
Active, closed
Viatris Innovation GmbH
Phase 3
451
Frankfurt am Main, Leipzig, Minden, Münster
2023-06-26
Active, closed
AbbVie
Observational
1,019
Heidelberg, Dachau, Erlangen, Kassel, Hanover, Minden, Remscheid, Worms
2023-06-09
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
43
Mannheim, Minden
2023-03-07
Active, closed
GlaxoSmithKline
Phase 3
163
Freiburg im Breisgau, Minden
2022-07-14
Active, closed
Bristol-Myers Squibb
Phase 3
729
Ratingen, Cologne, Erlangen, Hamburg, Magdeburg, Minden, Tübingen
2021-07-15
Recruiting
Device Global Registry for the IlluminOss Bone Stabilization System
NCT05206981Traumatic Fracture, Pathological Fracture
IlluminOss Medical, Inc.
Observational
300
Cologne, Minden, Wuppertal
2021-06-11
Active, closed
Pfizer
Phase 3
257
Tübingen, München, Bonn, Minden, Mainz, Dresden, Leipzig, Kiel
2021-01-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Göttingen, Minden, Münster, Neuss, Großhansdorf, Bad Berka, Jena, Berlin
2020-07-06
Active, closed
First in Men Study: BIOMAG-I
NCT04157153Coronary Artery Disease
Biotronik AG
Not applicable
116
Bad Segeberg, Kempten, Minden, Münich, Neuss
2020-04-27
Active, closed
Eli Lilly and Company
Phase 2
110
Jena, Mannheim, Minden
2012-05-22
Rows per page Showing 1–41 of 41
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/minden

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 41 of those studies with a site in Minden.

How many clinical trials are recruiting in Minden?

23 of the 41 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 17 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Minden), 41 studies
PhaseStudiesRecruitingShare
Phase 3221053.7%
Phase 29622%
Observational6414.6%
Not applicable214.9%
Phase 2/3224.9%

Most active sponsors

Lead sponsors with the most studies (Minden)
Lead sponsorStudiesRecruiting
Sanofi54
AbbVie30
GlaxoSmithKline32
Merck Sharp & Dohme LLC30
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS22
Viatris Innovation GmbH20
AIO-Studien-gGmbH11
AOP Orphan Pharmaceuticals AG10
argenx10
Artcline GmbH11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.